Who owns INOZYME PHARMA INC?
- Ticker: INZY
- CUSIP Number: 45790w108
Tip: Access positions for across all investors
Analyze quarterly positions in Inozyme Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Inozyme Pharma stock
Who bought or sold INOZYME PHARMA INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Adage Capital Partners GP | 5.5M | $23M | 30% | Sep 2023 |
|
Pivotal bioVenture Partners Investment Advisor | 4.5M | $19M | 23% | Sep 2023 |
|
Sofinnova Ventures | 4.3M | $18M | 17% | Sep 2023 |
|
Rock Springs Capital Management | 3.7M | $16M | 7% | Sep 2023 |
|
Samlyn Capital | 3.4M | $14M | 4% | Dec 2023 |
|
Eventide Asset Management | 3.2M | $14M | 2% | Dec 2023 |
|
FMR | 2.5M | $10M | 229% | Sep 2023 |
|
NEA Management Company | 2.4M | $10M | 0% | Dec 2023 |
|
Vanguard Group | 2.4M | $10M | 5% | Dec 2023 |
|
BlackRock | 2.2M | $9.4M | 15% | Sep 2023 |
|
Sphera Funds Management | 1.6M | $6.7M | 27% | Dec 2023 |
|
Samsara BioCapital | 1.6M | $6.7M | 0% | Dec 2023 |
|
Affinity Asset Advisors | 1.4M | $5.8M | 84% | Sep 2023 |
|
Blue Owl Capital Holdings | 1.3M | $5.4M | 100% | Dec 2023 |
|
CHI Advisors | 1.3M | $5.3M | 6% | Sep 2023 |
|
Millennium Management | 912k | $3.9M | -31% | Dec 2023 |
|
Geode Capital Management | 823k | $3.5M | 33% | Sep 2023 |
|
State Street Corporation | 628k | $2.6M | 12% | Sep 2023 |
|
Laurion Capital Management | 557k | $2.4M | -18% | Dec 2023 |
|
Knott David M Jr | 454k | $1.9M | 106% | Sep 2023 |
|
Octagon Capital Advisors | 400k | $1.7M | -69% | Dec 2023 |
|
Goldman Sachs Group | 363k | $1.5M | 574% | Dec 2023 |
|
Northern Trust | 335k | $1.4M | 11% | Sep 2023 |
|
MPM Oncology Impact Management | 327k | $1.4M | 0% | Sep 2023 |
|
Renaissance Technologies | 296k | $1.2M | 24% | Sep 2023 |
|
Kennedy Capital Management | 288k | $1.2M | 100% | Dec 2023 |
|
Susquehanna International | 254k | $1.1M | 349% | Sep 2023 |
|
Overbrook Management Corp. | 219k | $934k | 0% | Dec 2023 |
|
Parkman Healthcare Partners | 176k | $739k | 4% | Sep 2023 |
|
Citadel Advisors | 175k | $745k | 3% | Dec 2023 |
|
GSA Capital Partners | 167k | $711k | 80% | Dec 2023 |
|
Bank of New York Mellon | 158k | $673k | 12% | Dec 2023 |
|
UBS O'Connor | 155k | $652k | 0% | Sep 2023 |
|
Nuveen Asset Management | 138k | $579k | 0% | Sep 2023 |
|
Superstring Capital Management | 124k | $528k | 100% | Dec 2023 |
|
Charles Schwab Investment Management | 122k | $518k | 29% | Dec 2023 |
|
Schonfeld Strategic Advisors | 109k | $463k | -65% | Dec 2023 |
|
Bridgeway Capital Management | 92k | $385k | -21% | Sep 2023 |
|
Bank of America Corporation | 79k | $335k | -19% | Dec 2023 |
|
Two Sigma Advisers | 71k | $301k | -26% | Dec 2023 |
|
Barclays | 69k | $295k | 650% | Dec 2023 |
|
Dimensional Fund Advisors | 64k | $271k | 7% | Dec 2023 |
|
Rhumbline Advisers | 60k | $257k | 31% | Dec 2023 |
|
Two Sigma Investments | 54k | $229k | -21% | Dec 2023 |
|
Jane Street | 51k | $219k | 100% | Dec 2023 |
|
UBS Group | 46k | $197k | 144% | Dec 2023 |
|
AQR Capital Management | 46k | $196k | 133% | Dec 2023 |
|
ALPS Advisors | 42k | $180k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 34k | $147k | 56% | Dec 2023 |
|
Virtu Financial | 27k | $114k | 154% | Dec 2023 |
|
MetLife Investment Advisors | 27k | $113k | 47% | Dec 2023 |
|
Morgan Stanley | 26k | $111k | -21% | Sep 2023 |
|
American International | 24k | $101k | 40% | Dec 2023 |
|
Denali Advisors | 22k | $94k | -18% | Dec 2023 |
|
Bank Of Montreal | 22k | $99k | 100% | Dec 2023 |
|
SG Americas Securities | 21k | $90k | 47% | Dec 2023 |
|
Alliancebernstein | 18k | $78k | 0% | Dec 2023 |
|
American Century Companies | 18k | $76k | 48% | Sep 2023 |
|
Deutsche Bank Aktiengesellschaft | 16k | $69k | 0% | Dec 2023 |
|
Parallel Advisors | 16k | $68k | 3% | Dec 2023 |
|
Royal Bank of Canada | 15k | $65k | 166% | Dec 2023 |
|
Wells Fargo & Company | 15k | $63k | 74% | Dec 2023 |
|
Manufacturers Life Insurance Company | 15k | $61k | -1% | Sep 2023 |
|
Values First Advisors | 14k | $59k | 100% | Dec 2023 |
|
Ing Investment Management | 14k | $58k | 0% | Sep 2023 |
|
New York State Common Retirement Fund | 13k | $57k | -1% | Dec 2023 |
|
Invesco | 13k | $55k | 0% | Sep 2023 |
|
T. Rowe Price Associates | 13k | $55k | 100% | Dec 2023 |
|
Florida State Board of Administration | 12k | $53k | 100% | Dec 2023 |
|
Tower Research Capital | 8.3k | $35k | 134% | Sep 2023 |
|
California State Teachers Retirement System | 7.5k | $31k | -34% | Sep 2023 |
|
Citigroup | 6.7k | $27k | 37350% | Dec 2023 |
|
Summit Investment Advisors | 4.8k | $21k | 72% | Dec 2023 |
|
Legal & General Group | 4.0k | $17k | 35% | Dec 2023 |
|
Amalgamated Bank | 3.0k | $13k | -10% | Dec 2023 |
|
Metropolitan Life Insurance Company | 2.9k | $12k | 54% | Dec 2023 |
|
Group One Trading | 1.0k | $4.2k | -52% | Sep 2023 |
|
Advisor Group Holdings | 50.00 | $213.000000 | 0% | Dec 2023 |
|
Who sold out of Inozyme Pharma?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Deep Track Capital | Jun 2023 | 1.6M | $9.2M |
Point72 Asset Management | Sep 2023 | 700k | $2.9M |
Woodline Partners | Jun 2023 | 289k | $1.6M |
Eudaimonia Asset Management | Jun 2023 | 176k | $982k |
Marshall Wace | Sep 2023 | 136k | $570k |
Acadian Asset Management | Jun 2023 | 58k | $319k |
Mirae Asset Global Investments | Sep 2023 | 55k | $233k |
Squarepoint Ops | Sep 2023 | 43k | $179k |
Walleye Trading Advisors | Sep 2023 | 35k | $147k |
ExodusPoint Capital Management | Jun 2023 | 22k | $123k |
OTR - Nominee Name for The State Teachers Retirement Board of Ohio | Sep 2023 | 9.9k | $41k |
Dorsey Wright & Associates | Jun 2023 | 3.4k | $19k |
Simplex Trading | Sep 2023 | 1.0k | $4.0k |
Goss Wealth Management | Jun 2023 | 381.00 | $2.1k |
Us Bancorp | Sep 2023 | 129.00 | $542.006400 |